{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:11:29Z","timestamp":1793661089711,"version":"4.5.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpurol.2025.09.019","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:48:14Z","timestamp":1758599294000},"page":"105613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can inter-sphincteric and pelvic floor botulinum toxin type A injections enhance clinical outcomes in pediatric patients with non-neurogenic dysfunctional voiding?"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-6556","authenticated-orcid":false,"given":"Pooya","family":"Hekmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar Mohammadi","family":"Ganjaroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Hassanpour","family":"Dargah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9891-590X","authenticated-orcid":false,"given":"Mahdiyar","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Siri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-5321","authenticated-orcid":false,"given":"Alvand","family":"Naserghandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Mozafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-6285","authenticated-orcid":false,"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jpurol.2025.09.019_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/toxins14070498","article-title":"Clinical application of botulinum neurotoxin in lower-urinary-tract diseases and dysfunctions: where are we now and what more can we do?","volume":"14","author":"Kuo","year":"2022","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.jpurol.2025.09.019_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/toxins11120728","article-title":"The therapeutic effects and pathophysiology of botulinum toxin A on voiding dysfunction due to urethral sphincter dysfunction","volume":"11","author":"Kao","year":"2019","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.jpurol.2025.09.019_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/toxins16080339","article-title":"Intravesical botulin Toxin-A injections for neurogenic bladder dysfunction in children: Summary update on last 10 years of research","volume":"16","author":"Zulli","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.jpurol.2025.09.019_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11884-018-0478-z","article-title":"The role of chemical sphincterotomy with urethral botulinum toxin injection in patients with neurogenic and non-neurogenic failure to empty","volume":"13","author":"Boysen","year":"2018","journal-title":"Current Bladder Dysfunct Rep"},{"issue":"10","key":"10.1016\/j.jpurol.2025.09.019_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/toxins16100443","article-title":"Response to treatment with botulinum neurotoxin A (BoNT-A) in children and adolescents with neurogenic lower urinary tract dysfunction and idiopathic overactive bladder: a systematic review and meta-analysis","volume":"16","author":"Panunzio","year":"2024","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2025.09.019_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.juro.2006.03.119","article-title":"Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder","volume":"176","author":"Mokhless","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.urology.2009.09.087","article-title":"Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods","volume":"76","author":"Safari","year":"2010","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.jpurol.2025.09.019_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.juro.2013.10.034","article-title":"Long-term efficacy and durability of botulinum-A toxin for refractory dysfunctional voiding in children","volume":"191","author":"Vricella","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2025.09.019_bib10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.juro.2007.03.185","article-title":"The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children","volume":"178","author":"Franco","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib11","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.jpurol.2015.06.019","article-title":"Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children","volume":"12","author":"Greer","year":"2016","journal-title":"J Pediatr Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-5347(06)00298-9","article-title":"Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin?","volume":"176","author":"Radojicic","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2025.09.019_bib13","article-title":"Children with non-neurogenic lower urinary tract dysfunction require less frequent and number of botulinum toxin injections than neurogenic ones","volume":"9","author":"Gasimov","year":"2022","journal-title":"J Urol Surg"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpurol.2023.10.034","article-title":"The effect of botulinum toxin A in children with non-neurogenic therapy-refractory dysfunctional voiding\u2013A systematic review","volume":"20","author":"Hoelscher","year":"2024","journal-title":"J Pediatr Urol"},{"issue":"6","key":"10.1016\/j.jpurol.2025.09.019_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1053\/j.gastro.2016.02.015","article-title":"Childhood functional gastrointestinal disorders: child\/adolescent","volume":"150","author":"Hyams","year":"2016","journal-title":"Gastroenterology"},{"issue":"3 Part 2","key":"10.1016\/j.jpurol.2025.09.019_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-5347(05)67239-4","article-title":"The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children","volume":"164","author":"Farhat","year":"2000","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.jpurol.2025.09.019_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL\u2122 4.0: reliability and validity of the pediatric quality of life inventory\u2122 version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.jpurol.2025.09.019_bib18","first-page":"965","article-title":"Diagnosis and management of urinary incontinence and encopresis in childhood","volume":"2","author":"Nijman","year":"2005","journal-title":"Incontinence"},{"issue":"3","key":"10.1016\/j.jpurol.2025.09.019_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Sch\u00e4fer","year":"2002","journal-title":"Neurourol Urodyn: Off J Int Cont Soc"},{"key":"10.1016\/j.jpurol.2025.09.019_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1590\/s1677-5538.ibju.2018.0401","article-title":"Pelvic floor electromyography and urine flow patterns in children with vesicoureteral reflux and lower urinary tract symptoms","volume":"44","author":"Sharifi-Rad","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"6","key":"10.1016\/j.jpurol.2025.09.019_bib21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.juro.2014.01.110","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international Children\u2019s continence society","volume":"191","author":"Austin","year":"2014","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2025.09.019_bib22","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.jpurol.2014.10.006","article-title":"Breaking the vicious circle: onabotulinum toxin A in children with therapy-refractory dysfunctional voiding","volume":"11","author":"van den Hoek","year":"2015","journal-title":"J Pediatr Urol"},{"issue":"6","key":"10.1016\/j.jpurol.2025.09.019_bib23","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.juro.2012.01.126","article-title":"Can staccato and interrupted\/fractionated uroflow patterns alone correctly identify the underlying lower urinary tract condition?","volume":"187","author":"Wenske","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2025.09.019_bib24","series-title":"Recent advances in the field of urinary tract infections","article-title":"Developments regarding dysfunctional voiding and urinary tract infections in children","author":"Kibar","year":"2013"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/luts.12123","article-title":"Pathophysiological and therapeutic considerations for non-neurogenic lower urinary tract dysfunction in children","volume":"8","author":"Kakizaki","year":"2016","journal-title":"Low Urin Tract Symptoms"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib26","first-page":"76","article-title":"Vesicoureteral reflux in pediatric age: where are we today?","volume":"81","author":"Altobelli","year":"2014","journal-title":"Urol J"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-5347(05)65453-5","article-title":"The valve bladder syndrome: pathophysiology and treatment with nocturnal bladder emptying","volume":"167","author":"Koff","year":"2002","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpurol.2011.01.004","article-title":"Management of lower urinary tract dysfunction: a stepwise approach","volume":"8","author":"Thom","year":"2012","journal-title":"J Pediatr Urol"},{"issue":"2","key":"10.1016\/j.jpurol.2025.09.019_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5489\/cuaj.6975","article-title":"Canadian urological association guideline for the treatment of bladder dysfunction in children","volume":"15","author":"Afshar","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.juro.2014.07.097","article-title":"Biofeedback for nonneuropathic daytime voiding disorders in children: a systematic review and meta-analysis of randomized controlled trials","volume":"193","author":"Fazeli","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2025.09.019_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/978-1-4757-9542-4_70","article-title":"Therapeutic botulinum toxin: histologic effects and diffusion properties","author":"Borodic","year":"1993","journal-title":"Botulinum Tetanus Neurotoxins: Neurotransmission and Biomed Asp"},{"issue":"8","key":"10.1016\/j.jpurol.2025.09.019_bib32","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1517\/13543784.10.8.1531","article-title":"Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects","volume":"10","author":"Borodic","year":"2001","journal-title":"Expet Opin Invest Drugs"},{"issue":"9","key":"10.1016\/j.jpurol.2025.09.019_bib33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis","volume":"16","author":"Shaari","year":"1993","journal-title":"Muscle Nerve: Off J Am Assoc Electrodiagnostic Med"},{"issue":"3","key":"10.1016\/j.jpurol.2025.09.019_bib34","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.jpurol.2014.10.006","article-title":"Breaking the vicious circle: onabotulinum toxin A in children with therapy-refractory dysfunctional voiding","volume":"11","author":"Hoen","year":"2015","journal-title":"J Pediatr Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2025.09.019_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00383-008-2260-3","article-title":"Botulinum toxin in paediatric urology: a systematic literature review","volume":"25","author":"DasGupta","year":"2009","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"10.1016\/j.jpurol.2025.09.019_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpedsurg.2018.05.012","article-title":"Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: a preliminary report","volume":"54","author":"Al Edwan","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpurol.2025.09.019_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/30502225251346341","article-title":"The effect of intravesical injection of botulinum toxin A (BTX-A) on quality of life of pediatrics diagnosed with overactive bladder: a quasi-experimental study","volume":"12","author":"Al-Rimawi","year":"2025","journal-title":"Sage Open Pediatr"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513125005388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513125005388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T08:00:07Z","timestamp":1780214407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513125005388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1477513125005388"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2025.09.019","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can inter-sphincteric and pelvic floor botulinum toxin type A injections enhance clinical outcomes in pediatric patients with non-neurogenic dysfunctional voiding?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2025.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105613"}}